• Ronawk Announces New Chief Scientific Officer
    Ronawk Announces New Chief Scientific Officer
    News

    Ronawk Announces New Chief Scientific Officer

    Ronawk is excited to announce that Amy B. Manning-Boğ (pronounced: Boh), Ph.D., has joined us as our Chief Scientific Officer (CSO). Dr. Manning- Boğ’s experience in biotechnology start-ups, drug discovery, translational research, intellectual property, licensing, and va...
    News
    Ronawk Announces New Chief Scientific Officer

    Ronawk is excited to announce that Amy B. Manning-Boğ (pronounced: Boh), Ph.D., has joined us as our Chief Scientific Officer (CSO). Dr. Manning- Boğ’s experience in biotechnology start-ups, drug discovery, translational research, intellectual property, licensing, and va...

    6 January 2025

    News
    Micro-gRx, Ronawk, and University of Florida Collaborate on Translational Research in Advanced Tissue Engineering Aboard the International Space Station

    *Orlando, FL* – Micro-gRx, in partnership with Ronawk and the University of Florida, is excited to announce a collaboration on an innovative tissue engineering experiment. The study will advance in-space three-dimensional cell culture processes and study the effects of m...

    23 September 2024

    News
    Ronawk Joins the Wake Forest School of Medicine Institute for Regenerative Medicine and ReMDO Endeavors and Enters the Test Bed to Accelerate Next-Gen Therapies

    Ronawk, the leader in Advanced Tissue Mimetic Technologies, and the creator of the Bio-Block Universe®, announced today it is joining the RegenMed Development Organization (ReMDO) RegeneratOR Test Bed in Winston-Salem, North Carolina.  Ronawk’s Bio-Blocks™ are a 3D print...

    Ronawk Newsroom

    Ronawk is a biotech company founded in 2019 and based in Overland Park, Kansas. We are the creators of the Bio-Block, a revolutionary new substrate that mimics tissue and helps labs grow 3D cell cultures.

    Want to learn more?
    Visit ronawk.com or contact us at info@ronawk.com.

    Powered by